Details for: TMF1
Gene ID: 7110
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: TMF1
Ensembl ID: ENSG00000144747
Description: TATA element modulatory factor 1
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 57.1rCSI 50.21%PRS 19.36
-
CSI 47.97rCSI 55.47%PRS 19.62
-
CSI 20.61rCSI 25.5%PRS 23.27
-
CSI 19.41rCSI 14.68%PRS 35.72
-
CSI 17.41rCSI 22.81%PRS 37
-
CSI 13.12rCSI 36.92%PRS 32.02
-
CSI 11.95rCSI 27.24%PRS 26.68
-
CSI 9.72rCSI 15.75%PRS 26.34
-
CSI 9.24rCSI 12.59%PRS 22.93
-
CSI 8.96rCSI 8.94%PRS 22.61
-
CSI 8.77rCSI 20.94%PRS 38.01
-
CSI 7.83rCSI 18.6%PRS 38.09
-
CSI 7.76rCSI 19.7%PRS 25.73
-
CSI 7.63rCSI 7.05%PRS 45.32
-
CSI 6.9rCSI 13.3%PRS 55.45
-
CSI 6.23rCSI 4.74%PRS 34.81
-
CSI 6.17rCSI 8.4%PRS 55.12
-
CSI 6.15rCSI 6.42%PRS 62.17
-
CSI 5.94rCSI 4.45%PRS 40.12
-
CSI 5.57rCSI 5.36%PRS 27.26
-
CSI 5.31rCSI 3.94%PRS 37.86
-
CSI 4.92rCSI 30.74%PRS 21.08
-
CSI 4.79rCSI 17.93%PRS 22.21
-
CSI 4.73rCSI 10.56%PRS 30.9
-
CSI 4.69rCSI 3.89%PRS 25.15
-
CSI 4.55rCSI 7.32%PRS 17.54
-
CSI 4.41rCSI 14.19%PRS 27.2
-
CSI 4.27rCSI 6.57%PRS 33.39
-
CSI 4.19rCSI 3.47%PRS 26.81
-
CSI 4.05rCSI 3.14%PRS 25.71
-
CSI 4.02rCSI 9.02%PRS 16.71
-
CSI 3.9rCSI 5.01%PRS 25.2
-
CSI 3.78rCSI 5.36%PRS 24.5
-
CSI 3.5rCSI 2.07%PRS 36.94
-
CSI 3.48rCSI 3.42%PRS 39.91
-
CSI 3.41rCSI 2.98%PRS 34.49
-
CSI 3.31rCSI 4.12%PRS 35.98
-
CSI 3.24rCSI 8.56%PRS 31.44
-
CSI 3.23rCSI 10.92%PRS 39.23
-
CSI 3.22rCSI 2.38%PRS 22.61
-
CSI 3.19rCSI 4.87%PRS 33.77
-
CSI 3.13rCSI 5.96%PRS 40.88
-
CSI 2.89rCSI 67.24%PRS 47.22
-
CSI 2.88rCSI 2.31%PRS 44.98
-
CSI 2.88rCSI 2.42%PRS 40.64
-
CSI 2.87rCSI 2.95%PRS 41.11
-
CSI 2.85rCSI 4.45%PRS 54.02
-
CSI 2.85rCSI 13.65%PRS 22.92
-
CSI 2.76rCSI 4.73%PRS 35.01
-
CSI 2.63rCSI 3.86%PRS 24.35
-
CSI 2.5rCSI 2.03%PRS 27.49
-
CSI 2.44rCSI 1.7%PRS 36.56
-
CSI 2.42rCSI 1.81%PRS 62.9
-
CSI 2.41rCSI 3.28%PRS 38.37
-
CSI 2.38rCSI 1.88%PRS 18.22
-
CSI 2.32rCSI 2.28%PRS 28.29
-
CSI 2.29rCSI 2.39%PRS 27.07
-
CSI 2.24rCSI 1.77%PRS 31.69
-
CSI 2.22rCSI 7.14%PRS 35.41
-
CSI 2.19rCSI 2.04%PRS 26.4
-
CSI 2.19rCSI 3.54%PRS 37.95
-
CSI 2.18rCSI 6.32%PRS 29.44
-
CSI 2.17rCSI 2.9%PRS 33.36
-
CSI 2.15rCSI 2.74%PRS 30.29
-
CSI 2.13rCSI 23.19%PRS 47.25
-
CSI 2.13rCSI 2.01%PRS 27.63
-
CSI 2.11rCSI 3.61%PRS 50.6
-
CSI 2.1rCSI 2.07%PRS 70.15
-
CSI 2.1rCSI 2.63%PRS 33.93
-
CSI 2.06rCSI 1.78%PRS 37.89
-
CSI 2.06rCSI 2.48%PRS 31.72
-
CSI 2.05rCSI 6.06%PRS 30.62
-
CSI 2.04rCSI 4.51%PRS 24.34
-
CSI 2.01rCSI 3.37%PRS 16.07
-
CSI 2rCSI 2.09%PRS 24.66
-
CSI 1.99rCSI 4%PRS 19.62
-
CSI 1.98rCSI 1.76%PRS 26.58
-
CSI 1.98rCSI 4.09%PRS 36.7
-
CSI 1.98rCSI 2.71%PRS 29.78
-
CSI 1.97rCSI 1.31%PRS 30.85
-
CSI 1.96rCSI 2.71%PRS 34.63
-
CSI 1.94rCSI 1.51%PRS 38.54
-
CSI 1.94rCSI 1.91%PRS 60.15
-
CSI 1.91rCSI 2.24%PRS 30.07
-
CSI 1.91rCSI 2.21%PRS 37.15
-
CSI 1.9rCSI 7.75%PRS 26.8
-
CSI 1.87rCSI 10.19%PRS 53.49
-
CSI 1.87rCSI 2.1%PRS 40.92
-
CSI 1.87rCSI 4.49%PRS 40.73
-
CSI 1.86rCSI 1.39%PRS 42.74
-
CSI 1.86rCSI 8.17%PRS 23.65
-
CSI 1.85rCSI 1.23%PRS 55.62
-
CSI 1.84rCSI 3.24%PRS 25.66
-
CSI 1.84rCSI 4.19%PRS 22.59
-
CSI 1.83rCSI 2.27%PRS 28.26
-
CSI 1.83rCSI 2.19%PRS 25.54
-
CSI 1.82rCSI 5.41%PRS 35.82
-
CSI 1.79rCSI 3.62%PRS 14.68
-
CSI 1.78rCSI 5.78%PRS 30.9
-
CSI 1.78rCSI 1.28%PRS 35.99
-
CSI 0.1rCSI 1.1%PRS 44.3%
-
CSI 0.2rCSI 1.2%PRS 59.4%
-
CSI 0.2rCSI 1.0%PRS 42.7%
-
CSI 0.2rCSI 1.8%PRS 45.8%
-
CSI 0.2rCSI 1.1%PRS 44.6%
-
CSI 0.3rCSI 1.7%PRS 47.5%
-
CSI 0.3rCSI 0.5%PRS 15.7%
-
CSI 0.3rCSI 0.7%PRS 39.1%
-
CSI 0.3rCSI 1.6%PRS 37.9%
-
CSI 0.3rCSI 0.5%PRS 39.3%
-
CSI 0.3rCSI 0.9%PRS 20.7%
-
CSI 0.4rCSI 3.9%PRS 55.5%
-
CSI 0.4rCSI 1.8%PRS 42.6%
-
CSI 0.4rCSI 0.6%PRS 33.8%
-
CSI 0.4rCSI 2.2%PRS 55.1%
-
CSI 0.4rCSI 2.2%PRS 53.1%
-
CSI 0.4rCSI 2.9%PRS 17.0%
-
CSI 0.4rCSI 2.3%PRS 48.7%
-
CSI 0.5rCSI 0.7%PRS 14.9%
-
CSI 0.5rCSI 0.8%PRS 28.9%
-
CSI 0.5rCSI 0.6%PRS 49.3%
-
CSI 0.5rCSI 0.8%PRS 36.0%
-
CSI 0.6rCSI 1.1%PRS 42.6%
-
CSI 0.6rCSI 1.2%PRS 48.7%
-
CSI 0.6rCSI 0.9%PRS 26.6%
-
CSI 0.6rCSI 2.2%PRS 16.7%
-
CSI 0.6rCSI 3.4%PRS 37.7%
-
CSI 0.6rCSI 0.5%PRS 45.3%
-
CSI 0.6rCSI 1.7%PRS 45.1%
-
CSI 0.6rCSI 0.9%PRS 34.4%
-
CSI 0.6rCSI 0.5%PRS 29.5%
-
CSI 0.6rCSI 0.6%PRS 31.1%
-
CSI 0.6rCSI 0.8%PRS 47.2%
-
CSI 0.6rCSI 1.7%PRS 34.0%
-
CSI 0.6rCSI 1.4%PRS 39.1%
-
CSI 0.6rCSI 1.6%PRS 20.2%
-
CSI 0.6rCSI 1.1%PRS 19.7%
-
CSI 0.6rCSI 0.9%PRS 40.0%
-
CSI 0.6rCSI 1.8%PRS 41.7%
-
CSI 0.6rCSI 2.0%PRS 22.6%
-
CSI 0.6rCSI 3.0%PRS 52.0%
-
CSI 0.7rCSI 3.7%PRS 65.4%
-
CSI 0.7rCSI 15.7%PRS 15.8%
-
CSI 0.7rCSI 1.4%PRS 47.5%
-
CSI 0.7rCSI 1.0%PRS 20.7%
-
CSI 0.7rCSI 1.8%PRS 26.4%
-
CSI 0.7rCSI 1.3%PRS 33.5%
-
CSI 0.7rCSI 10.9%PRS 56.4%
-
CSI 0.7rCSI 2.5%PRS 43.0%
-
CSI 0.7rCSI 4.2%PRS 16.9%
-
CSI 0.7rCSI 1.1%PRS 24.3%
-
CSI 0.7rCSI 2.8%PRS 42.5%
-
CSI 0.7rCSI 2.0%PRS 40.0%
-
CSI 0.7rCSI 1.3%PRS 55.9%
-
CSI 0.7rCSI 1.3%PRS 33.7%
-
CSI 0.7rCSI 2.0%PRS 22.1%
-
CSI 0.7rCSI 0.5%PRS 32.8%
-
CSI 0.7rCSI 4.0%PRS 43.2%
-
CSI 0.8rCSI 2.7%PRS 67.2%
-
CSI 0.8rCSI 2.1%PRS 24.7%
-
CSI 0.8rCSI 1.8%PRS 31.9%
-
CSI 0.8rCSI 2.3%PRS 43.8%
-
CSI 0.8rCSI 2.7%PRS 60.7%
-
CSI 0.8rCSI 1.3%PRS 27.0%
-
CSI 0.8rCSI 1.0%PRS 44.2%
-
CSI 0.8rCSI 20.0%PRS 14.9%
-
CSI 0.8rCSI 0.7%PRS 26.6%
-
CSI 0.9rCSI 0.7%PRS 33.0%
-
CSI 0.9rCSI 1.3%PRS 29.2%
-
CSI 0.9rCSI 3.9%PRS 74.7%
-
CSI 0.9rCSI 1.8%PRS 27.3%
-
CSI 0.9rCSI 1.9%PRS 40.4%
-
CSI 0.9rCSI 0.9%PRS 49.8%
-
CSI 0.9rCSI 1.3%PRS 30.0%
-
CSI 0.9rCSI 1.3%PRS 28.1%
-
CSI 0.9rCSI 1.7%PRS 48.0%
-
CSI 0.9rCSI 1.1%PRS 15.9%
-
CSI 0.9rCSI 10.5%PRS 66.8%
-
CSI 0.9rCSI 1.4%PRS 43.9%
-
CSI 0.9rCSI 1.0%PRS 27.2%
-
CSI 0.9rCSI 2.6%PRS 41.7%
-
CSI 1.0rCSI 1.2%PRS 30.3%
-
CSI 1.0rCSI 3.7%PRS 24.5%
-
CSI 1.0rCSI 2.4%PRS 24.6%
-
CSI 1.0rCSI 1.4%PRS 29.2%
-
CSI 1.0rCSI 3.1%PRS 18.4%
-
CSI 1.0rCSI 1.8%PRS 21.9%
-
CSI 1.0rCSI 4.9%PRS 35.3%
-
CSI 1.0rCSI 2.4%PRS 15.7%
-
CSI 1.0rCSI 2.6%PRS 24.4%
-
CSI 1.0rCSI 1.6%PRS 24.8%
-
CSI 1.1rCSI 1.4%PRS 30.3%
-
CSI 1.1rCSI 1.8%PRS 47.4%
-
CSI 1.1rCSI 1.6%PRS 26.6%
-
CSI 1.1rCSI 1.0%PRS 31.4%
-
CSI 1.1rCSI 1.3%PRS 32.6%
-
CSI 1.1rCSI 9.3%PRS 15.6%
-
CSI 1.1rCSI 2.6%PRS 37.4%
-
CSI 1.1rCSI 2.9%PRS 48.3%
-
CSI 1.1rCSI 1.4%PRS 16.7%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 1592143362
Symbol: TMF1_HUMAN
Name: TATA element modulatory factor
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 1409643
Title: Cloning and chromosomal mapping of a human immunodeficiency virus 1 'TATA' element modulatory factor.
PubMed ID: 1409643
PubMed ID: 10428808
Title: Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells.
PubMed ID: 10428808
PubMed ID: 16641997
Title: The DNA sequence, annotation and analysis of human chromosome 3.
PubMed ID: 16641997
DOI: 10.1038/nature04728
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 12044884
Title: A putative nuclear receptor coactivator (TMF/ARA160) associates with hbrm/hSNF2 alpha and BRG-1/hSNF2 beta and localizes in the Golgi apparatus.
PubMed ID: 12044884
PubMed ID: 15467733
Title: TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3.
PubMed ID: 15467733
PubMed ID: 17698061
Title: Functional involvement of TMF/ARA160 in Rab6-dependent retrograde membrane traffic.
PubMed ID: 17698061
PubMed ID: 18691976
Title: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.
PubMed ID: 18691976
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 20068231
Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
PubMed ID: 20068231
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
Sequence Information:
- Length: 1093
- Mass: 122842
- Checksum: 566BBE3EC36EF11C
- Sequence:
MSWFNASQLS SFAKQALSQA QKSIDRVLDI QEEEPSIWAE TIPYGEPGIS SPVSGGWDTS TWGLKSNTEP QSPPIASPKA ITKPVRRTVV DESENFFSAF LSPTDVQTIQ KSPVVSKPPA KSQRPEEEVK SSLHESLHIG QSRTPETTES QVKDSSLCVS GETLAAGTSS PKTEGKHEET VNKESDMKVP TVSLKVSESV IDVKTTMESI SNTSTQSLTA ETKDIALEPK EQKHEDRQSN TPSPPVSTFS SGTSTTSDIE VLDHESVISE SSASSRQETT DSKSSLHLMQ TSFQLLSASA CPEYNRLDDF QKLTESCCSS DAFERIDSFS VQSLDSRSVS EINSDDELSG KGYALVPIIV NSSTPKSKTV ESAEGKSEEV NETLVIPTEE AEMEESGRSA TPVNCEQPDI LVSSTPINEG QTVLDKVAEQ CEPAESQPEA LSEKEDVCKT VEFLNEKLEK REAQLLSLSK EKALLEEAFD NLKDEMFRVK EESSSISSLK DEFTQRIAEA EKKVQLACKE RDAAKKEIKN IKEELATRLN SSETADLLKE KDEQIRGLME EGEKLSKQQL HNSNIIKKLR AKDKENENMV AKLNKKVKEL EEELQHLKQV LDGKEEVEKQ HRENIKKLNS MVERQEKDLG RLQVDMDELE EKNRSIQAAL DSAYKELTDL HKANAAKDSE AQEAALSREM KAKEELSAAL EKAQEEARQQ QETLAIQVGD LRLALQRTEQ AAARKEDYLR HEIGELQQRL QEAENRNQEL SQSVSSTTRP LLRQIENLQA TLGSQTSSWE KLEKNLSDRL GESQTLLAAA VERERAATEE LLANKIQMSS MESQNSLLRQ ENSRFQAQLE SEKNRLCKLE DENNRYQVEL ENLKDEYVRT LEETRKEKTL LNSQLEMERM KVEQERKKAI FTQETIKEKE RKPFSVSSTP TMSRSSSISG VDMAGLQTSF LSQDESHDHS FGPMPISANG SNLYDAVRMG AGSSIIENLQ SQLKLREGEI THLQLEIGNL EKTRSIMAEE LVKLTNQNDE LEEKVKEIPK LRTQLRDLDQ RYNTILQMYG EKAEEAEELR LDLEDVKNMY KTQIDELLRQ SLS
Genular Protein ID: 449504758
Symbol: Q6PII6_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
Sequence Information:
- Length: 533
- Mass: 58382
- Checksum: 51F5A8BA05E087FA
- Sequence:
MSWFNASQLS SFAKQALSQA QKSIDRVLDI QEEEPSIWAE TIPYGEPGIS SPVSGGWDTS TWGLKSNTEP QSPPIASPKA ITKPVRRTVV DESENFFSAF LSPTDVQTIQ KSPVVSKPPA KSQRPEEEVK SSLHESLHIG QSRTPETTES QVKDSSLCVS GETLAAGTSS PKTEGKHEET VNKESDMKVP TVSLKVSESV IDVKTTMESI SNTSTQSLTA ETKDIALEPK EQKHEDRQSN TPSPPVSTFS SGTSTTSDIE VLDHESVISE SSASSRQETT DSKSSLHLMQ TSFQLLSASA CPEYNRLDDF QKLTESCCSS DAFERIDSFS VQSLDSRSVS EINSDDELSG KGYALVPIIV NSSTPKSKTV ESAEGKSEEV NETLVIPTEE AEMEESGRSA TPVNCEQPDI LVSSTPINEG QTVLDKVAEQ CEPAESQPEA LSEKEDVCKT VEFLNEKLEK REAQLLSLSK EKALLEEAFD NLKDEMFRVK EESSSISSLK DEFTQRIAEA EKKVQLACKE RDAAKKEIKK KKK